To include your compound in the COVID-19 Resource Center, submit it here.

Influenza vaccine: Phase III

BAX subsidiary Baxter Hyland Immuno (Orth/Donau, Austria) reported that in

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE